USAID: Prominent Health Care Companies Partner with USAID to Combat Drug-Resistant Tuberculosis
“The U.S. Agency for International Development (USAID) announced two new partnerships [Thursday] to add resources and cutting-edge technologies to fight drug-resistant tuberculosis (TB). Janssen, the pharmaceutical arm of Johnson & Johnson, announced a $15-20 million pledge as part of a new partnership with USAID to combat multidrug-resistant tuberculosis (MDR-TB). USAID will also partner with Cepheid, a maker of molecular systems and tests, to speed diagnosis of MDR-TB through increased access to rapid, accurate diagnostic tools…” (1/7).